Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients
暂无分享,去创建一个
David Touboul | Charles Duyckaerts | Alain Brunelle | Olivier Laprévote | Catherine Marquer | C. Duyckaerts | L. Dauphinot | C. Marquer | A. Lazar | D. Touboul | A. Brunelle | O. Laprévote | Luce Dauphinot | N. Desbenoit | Claudia Bich | Nicolas Desbenoit | Adina N. Lazar | Maï Panchal | Vanessa W. Petit | C. Bich | M. Panchal | V. Petit
[1] Thomas W. Mühleisen,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.
[2] S. Melov,et al. Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. , 2005, The Journal of clinical investigation.
[3] P. R. Hof,et al. Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: A quantitative analysis of six cases , 2004, Acta Neuropathologica.
[4] L. Kiemeney,et al. Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.
[5] Douglas Walker,et al. Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. , 2002, Biochemistry.
[6] L. Lue,et al. Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production. , 2008, Neurobiology of disease.
[7] F. Pfrieger. Role of cholesterol in synapse formation and function. , 2003, Biochimica et biophysica acta.
[8] E. Weibel. Practical methods for biological morphometry , 1979 .
[9] C. Gottfries,et al. Membrane Components Separate Early-Onset Alzheimer's Disease From Senile Dementia of the Alzheimer Type , 1996, International Psychogeriatrics.
[10] T. Ohm,et al. Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons , 2001, Acta Neuropathologica.
[11] J. Cleary,et al. Amyloid beta-peptide1-40 increases neuronal membrane fluidity: role of cholesterol and brain region. , 2001, Journal of lipid research.
[12] J. Morrison,et al. Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[13] C. Duyckaerts,et al. Enrichment of cholesterol in microdissected Alzheimer's disease senile plaques as assessed by mass spectrometry , 2010, Journal of Lipid Research.
[14] Nick C Fox,et al. Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .
[15] Charles Duyckaerts,et al. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.
[16] J. Rossier,et al. Clathrin-dependent APP endocytosis and Abeta secretion are highly sensitive to the level of plasma membrane cholesterol. , 2010, Biochimica et biophysica acta.
[17] Charles Duyckaerts,et al. Tau, paired helical filaments and amyloid in the neocortex: a morphometric study of 15 cases with graded intellectual status in aging and senile dementia of Alzheimer type , 2004, Acta Neuropathologica.
[18] C. Duyckaerts,et al. Laminar distribution of neocortical senile plaques in senile dementia of the alzheimer type , 2004, Acta Neuropathologica.
[19] E. Ikonen,et al. Caveolins and Cellular Cholesterol Balance , 2000, Traffic.
[20] C. Duyckaerts,et al. Local cholesterol increase triggers amyloid precursor protein‐Bacel clustering in lipid rafts and rapid endocytosis , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] Yu-Min Kuo,et al. Increased Aβ Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer's Disease† , 2002 .
[22] M. Dhenain,et al. Morphological and chemical studies of pathological human and mice brain at the subcellular level: Correlation between light, electron, and nanosims microscopies , 2007, Microscopy research and technique.
[23] D. Touboul,et al. Structural analysis of secondary ions by post-source decay in time-of-flight secondary ion mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.
[24] D. Touboul,et al. Micrometric molecular histology of lipids by mass spectrometry imaging. , 2011, Current opinion in chemical biology.
[25] John Woulfe,et al. Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production , 2008, Neurobiology of Disease.
[26] J. Lausmaa,et al. Mass spectrometric imaging of lipids in brain tissue. , 2004, Analytical chemistry.
[27] B. Hagenhoff,et al. Distribution of cholesterol and galactosylceramide in rat cerebellar white matter. , 2006, Biochimica et biophysica acta.
[28] C. Duyckaerts,et al. Cholesterol in the senile plaque: often mentioned, never seen , 2008, Acta Neuropathologica.
[29] Rudolph E. Tanzi,et al. Alzheimer's disease: the cholesterol connection , 2003, Nature Neuroscience.
[30] M J Campbell,et al. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[31] F. Benes,et al. Laminar-specific distribution and infrastructural detail of amyloid in the Alzheimer disease cortex visualized by computer-enhanced imaging of epitopes recognized by monoclonal antibodies. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Armstrong. Laminar Distribution of β-Amyloid Deposits in Dementia With Lewy Bodies and in Alzheimer’s Disease , 2006 .
[33] C. Duyckaerts,et al. Cholesterol changes in Alzheimer's disease: methods of analysis and impact on the formation of enlarged endosomes. , 2010, Biochimica et biophysica acta.
[34] Per Malmberg,et al. Bioimaging TOF‐SIMS: localization of cholesterol in rat kidney sections , 2004, FEBS letters.
[35] P. Bosco,et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.
[36] M. Mattson,et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[37] C. Morris,et al. The imaging and quantification of aluminium in the human brain using dynamic secondary ion mass spectrometry (SIMS) , 1992, Biology of the cell.
[38] E. Ikonen,et al. Functional rafts in cell membranes , 1997, Nature.
[39] Marie-Claude Potier,et al. Classification and basic pathology of Alzheimer disease , 2009, Acta Neuropathologica.
[40] S. Melov,et al. Alzheimer disease β-amyloid activity mimics cholesterol oxidase , 2005 .
[41] David Touboul,et al. Improvement of biological time-of-flight-secondary ion mass spectrometry imaging with a bismuth cluster ion source , 2005, Journal of the American Society for Mass Spectrometry.
[42] J. Schneider,et al. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.
[43] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[44] D. Volmer,et al. Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients , 2009, Neurobiology of Disease.
[45] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[46] T. Ohm,et al. Cholesterol and Tau Protein - Findings in Alzheimer’s and Niemann Pick C’s Disease , 2003, Pharmacopsychiatry.
[47] F. Halgand,et al. Tissue molecular ion imaging by gold cluster ion bombardment. , 2004, Analytical chemistry.
[48] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.